TERESA RIDER: Open Payments
NPI 1659645273 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,185 in 80 payments from 20 companies in 2025. Trend: 2023 $716 · 2024 $1,109 · 2025 $1,185
Food & beverage: $1,162Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $302 |
| Vanda Pharmaceuticals Inc. | 12 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $141 |
| PFIZER INC. | 9 | $135 |
| Lundbeck LLC | 3 | $51 |
| Indivior Inc. | 3 | $49 |
| Gilead Sciences, Inc. | 2 | $42 |
| Corium, LLC | 2 | $34 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Alkermes, Inc. | 1 | $28 |
Products named: FANAPT, VRAYLAR, CAPLYTA, NURTEC ODT, QULIPTA, REXULTI, SUBLOCADE, Azstarys.
Industry payments across IN — which companies pay providers there.
